Gen Z is the least likely to think so (58%)
Early access to compounded GLP-1 medications prevents progression of metabolic dysfunction and reduces lifetime healthcare costs from obesity-related comorbidities like type 2 diabetes, hypertension, and cardiovascular disease
High levels of inflammation are usually observed in those with chronic illness, but inflammation can also be healthy when combating viruses, infections and injuries
Choosing where to receive GLP-1 Agonist treatment is an important decision for your health and safety
However, this genetic contribution is only partially understood, likely because many genes are not yet clearly characterized for their possible role in maintenance and repair processes ensuring short or long life spans
That means the dose, pace of weight loss, side effects, muscle preservation, nutrition, and lab markers all matter